Home
|Insights
|"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

Speaking Engagement | 09.09.10

Contacts

Keith J. Harrison
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2560
a2hhcnJpc29uQGNyb3dlbGwuY29t

Insights

Speaking Engagement | 04.18.24

"Best Practices for Responding to Subpoenas," Responding to Government Investigations: The Latest Developments and Strategies for Government Contractors, Washington, D.C.

Speaking Engagement | 04.18.24
"Cloudy with a Chance of Claims: Claims during a Time of Uncertainty," OOPS 2024: Government Contracts Weathering a Dynamic Forecast, Washington, D.C.
Speaking Engagement | 04.18.24
"Cost & Pricing Trends on Our Radar," OOPS 2024: Government Contracts Weathering a Dynamic Forecast, Washington, D.C.
Speaking Engagement | 04.18.24
"Expansion of Technology Driven Infrastructure – Areas to Watch in 2024," OOPS 2024: Government Contracts Weathering a Dynamic Forecast, Washington, D.C.

View All Insights

Subscribe

to the latest insights from our team